BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 8437112)

  • 1. Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs.
    Howell RE; Sickels BD; Woeppel SL
    J Pharmacol Exp Ther; 1993 Feb; 264(2):609-15. PubMed ID: 8437112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.
    Underwood DC; Kotzer CJ; Bochnowicz S; Osborn RR; Luttmann MA; Hay DW; Torphy TJ
    J Pharmacol Exp Ther; 1994 Jul; 270(1):250-9. PubMed ID: 8035322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of neurally mediated nonadrenergic, noncholinergic contractions of guinea pig bronchus by isozyme-selective phosphodiesterase inhibitors.
    Undem BJ; Meeker SN; Chen J
    J Pharmacol Exp Ther; 1994 Nov; 271(2):811-7. PubMed ID: 7965800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibition by selective phosphodiesterase inhibitors of antigen, LTC4 and histamine-induced contraction of guinea-pig isolated trachea.
    Planquois JM; Ruffin-Morin Y; Lagente V; Payne AN; Dahl SG
    Pulm Pharmacol; 1996 Aug; 9(4):251-8. PubMed ID: 9160414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of inhibitors of phosphodiesterase, on antigen-induced bronchial hyperreactivity in conscious sensitized guinea-pigs and airway leukocyte infiltration.
    Danahay H; Broadley KJ
    Br J Pharmacol; 1997 Jan; 120(2):289-97. PubMed ID: 9117122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram.
    Underwood DC; Osborn RR; Novak LB; Matthews JK; Newsholme SJ; Undem BJ; Hand JM; Torphy TJ
    J Pharmacol Exp Ther; 1993 Jul; 266(1):306-13. PubMed ID: 8392555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of bronchospasm and ozone-induced airway hyperresponsiveness in the guinea-pig by CDP840, a novel phosphodiesterase type 4 inhibitor.
    Holbrook M; Gozzard N; James T; Higgs G; Hughes B
    Br J Pharmacol; 1996 Jul; 118(5):1192-200. PubMed ID: 8818343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary effects of type V cyclic GMP specific phosphodiesterase inhibition in the anaesthetized guinea-pig.
    Turner NC; Dolan JS; Grimsditch D; Lamb J; Worby A; Murray KJ; Coates WJ; Warrington BH
    Br J Pharmacol; 1994 Apr; 111(4):1198-204. PubMed ID: 8032606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of selective phosphodiesterase inhibitors on platelet-activating factor- and antigen-induced airway hyperreactivity, eosinophil accumulation, and microvascular leakage in guinea pigs.
    Ortiz JL; Vallés JM; Martí-Cabrera M; Cortijo J; Morcillo EJ
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jan; 353(2):200-6. PubMed ID: 8717161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor.
    Raeburn D; Underwood SL; Lewis SA; Woodman VR; Battram CH; Tomkinson A; Sharma S; Jordan R; Souness JE; Webber SE
    Br J Pharmacol; 1994 Dec; 113(4):1423-31. PubMed ID: 7889300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of relaxant responses evoked by a nitric oxide donor and by nonadrenergic, noncholinergic stimulation by isozyme-selective phosphodiesterase inhibitors in guinea pig trachea.
    Ellis JL; Conanan ND
    J Pharmacol Exp Ther; 1995 Mar; 272(3):997-1004. PubMed ID: 7891355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of lipopolysaccharide-induced pulmonary edema by isozyme-selective phosphodiesterase inhibitors in guinea pigs.
    Howell RE; Jenkins LP; Howell DE
    J Pharmacol Exp Ther; 1995 Nov; 275(2):703-9. PubMed ID: 7473157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential use of selective phosphodiesterase inhibitors in the treatment of asthma.
    Murray KJ; Eden RJ; England PJ; Dolan J; Grimsditch DC; Stutchbury CA; Patel B; Reeves ML; Worby A; Torphy TJ
    Agents Actions Suppl; 1991; 34():27-46. PubMed ID: 1665307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of endogenous catecholamines on the inhibitory effects of rolipram against early- and late-phase response to antigen in the guinea pig.
    Underwood DC; Matthews JK; Osborn RR; Bochnowicz S; Torphy TJ
    J Pharmacol Exp Ther; 1997 Jan; 280(1):210-9. PubMed ID: 8996198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C(4)-induced contractions in passively sensitized human airways.
    Schmidt DT; Watson N; Dent G; Rühlmann E; Branscheid D; Magnussen H; Rabe KF
    Br J Pharmacol; 2000 Dec; 131(8):1607-18. PubMed ID: 11139438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4.
    Hughes B; Howat D; Lisle H; Holbrook M; James T; Gozzard N; Blease K; Hughes P; Kingaby R; Warrellow G; Alexander R; Head J; Boyd E; Eaton M; Perry M; Wales M; Smith B; Owens R; Catterall C; Lumb S; Russell A; Allen R; Merriman M; Bloxham D; Higgs G
    Br J Pharmacol; 1996 Jul; 118(5):1183-91. PubMed ID: 8818342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase inhibitors reduce bronchial hyperreactivity and airway inflammation in unrestrained guinea pigs.
    Santing RE; Olymulder CG; Van der Molen K; Meurs H; Zaagsma J
    Eur J Pharmacol; 1995 Feb; 275(1):75-82. PubMed ID: 7774665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple mechanisms of xanthine actions on airway reactivity.
    Howell RE
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1008-14. PubMed ID: 2175791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential in vivo and in vitro bronchorelaxant activities of CP-80,633, a selective phosphodiesterase 4 inhibitor.
    Wright KF; Turner CR; Jayasinghe-Beck R; Cohen VL; Cheng JB; Watson JW
    Can J Physiol Pharmacol; 1997 Aug; 75(8):1001-8. PubMed ID: 9360015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.